Gregory J. Ahmann
Mayo Clinic · 122 works · 5,834 citations · h-index 33
Top works
- Initial genome sequencing and analysis of multiple myeloma
- Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
- Genomic abnormalities in monoclonal gammopathy of undetermined significance
- The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
- A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies
- Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis
- Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions
- Plasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosis
- Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma
- CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.
- Systemic therapy of myeloma xenografts by an attenuated measles virus
- Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations
- Detection of myeloma cells in the peripheral blood by flow cytometry
- Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications.
- Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.
- Comparison of Interleukin-1β Expression by In Situ Hybridization in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
- Chromosomal abnormalities in systemic amyloidosis
- 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance
- Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity?
- Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications